NL63 BY PCR

NL63 BY PCR is a laboratory molecular test that detects the presence of Human Coronavirus NL63 RNA using reverse transcription polymerase chain reaction (RT‑PCR). The test identifies active infection by amplifying viral genetic material from an upper respiratory swab, providing sensitive and specific detection that helps distinguish NL63 from other respiratory viruses. Fast, lab‑certified results with professional home sample collection across Dubai and the UAE support timely clinical decisions, infection control and appropriate patient management.

• Human Coronavirus NL63 RNA (Qualitative: Detected / Not detected)
• Cycle threshold (Ct) value (reported when applicable)
• Internal control (sample extraction and amplification validity)
• Assay validity status (Valid / Invalid)

• Acute upper respiratory symptoms (cough, sore throat, nasal congestion)
• Fever with respiratory illness where NL63 is suspected
• Close contact with a confirmed NL63 case or cluster of respiratory infections
• Immunocompromised patients with unexplained respiratory symptoms
• To guide infection control in household or care‑facility outbreaks

• High‑sensitivity RT‑PCR detection specific for NL63
• Professional at‑home sample collection across Dubai and UAE
• Fast, lab‑certified results suitable for UAE healthcare use
• Clear reporting including Ct value and assay validity
• Results and guidance compatible with local clinical and public health requirements

• At‑home nasopharyngeal or oropharyngeal swab collection by trained phlebotomist
• Do not use nasal sprays or perform nasal irrigation 2 hours prior to sampling
• Have Emirates ID / passport available for patient identification
• Please inform the collector of recent antiviral or immunosuppressive therapy